<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04218292</url>
  </required_header>
  <id_info>
    <org_study_id>PMCF 24October2019</org_study_id>
    <secondary_id>KAM-P4-21-01</secondary_id>
    <nct_id>NCT04218292</nct_id>
  </id_info>
  <brief_title>Micro Plug Set - Post Market Clinical Follow-up (PMCF) Plan</brief_title>
  <official_title>Dr. Amplatz Micro Plug - Post Market Clinical Follow-up (PMCF) Plan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KA Medical, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merit Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>KA Medical, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, post market clinical follow-up (PMCF) intended to evaluate the&#xD;
      residual risks of the Micro Plug Set which is intended for use during arterial embolization&#xD;
      of the peripheral vasculature. This PMCF will collect data pertaining to any adverse events&#xD;
      as well as the identification of any unanticipated risks up to the first 12 months following&#xD;
      device implant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 31, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of serious device-related and procedure-related adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of serious device-related and procedure-related adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of successful delivery of the device</measure>
    <time_frame>1 day</time_frame>
    <description>Rate of successful delivery of the Micro Plug device to the intended position.</description>
  </secondary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Trauma Injury</condition>
  <condition>Bleeding</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Micro Plug Set</intervention_name>
    <description>The Micro Plug Set is indicated for arterial embolization in the peripheral vasculature.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring routine standard of care for peripheral embolization. Some of the&#xD;
        patients will be liver cancer patients undergoing palliative treatment with SIRT who have a&#xD;
        life expectancy that may be less than 12 months. Other patients may be treated for trauma&#xD;
        or bleeding.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is scheduled for arterial embolization in the peripheral vasculature.&#xD;
&#xD;
          -  Subject is greater than 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is unable to give informed consent&#xD;
&#xD;
          -  Subject is pregnant or breastfeeding&#xD;
&#xD;
          -  Subject has allergy to nickel&#xD;
&#xD;
          -  Patient requires neurologic or cardiac use of an occlusion device, contrary to the&#xD;
             Micro Plug Set Instructions For Use.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maciej Pech, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Magdeburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 2, 2020</study_first_submitted>
  <study_first_submitted_qc>January 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2020</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

